Results

Total Results: 925 records

Showing results for "diabetic".
Users also searched for: diabetes

121. Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/hbSopN6uA9u-4EQuKtRGDP
     October 01, 2011 - interventions, orlistat, and met- formin all led to declines in fasting glucose levels in prediabetic and diabetic … (0.672 mmol/L [12.1 mg/dL] greater than placebo), possibly because those studies were conducted in diabetic … interventions (considered comparative effectiveness), including Look AHEAD, a weight-loss intervention trial in diabetic … Comparison of orlistat treatment and placebo in obese type 2 diabetic patients.

122. Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Clinical Summary (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3khZ9a2mY7eYPVhNY5ZdkC
     April 04, 2019 - Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Clinical Summary Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Clinical Summary Population Adults aged 40 to 70 y who are overweight or obese Recommendation Screen for abnormal blood glucose. Offer or refer patients…

123. Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Prediabetes and Type 2 Diabetes | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/uspstf/uspstf/announcements/draft-recstatement-prediabetes-type2dm-screening
     April 12, 2021 - Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Prediabetes and Type 2 Diabetes Share to Facebook Share to X Share to WhatsApp Share to Email Print March 16, 2021 – The U.S. Preventive Services Task F…

124. Final Recommendation Statement: Screening for Gestational Diabetes | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-screening-gestational-diabetes
     August 10, 2021 - Final Recommendation Statement: Screening for Gestational Diabetes Share to Facebook Share to X Share to WhatsApp Share to Email Print August 10, 2021 – The U.S. Preventive Services Task Force released today a final recommendation statement …

125. U.S. Preventive Task Force Recommends Screening Adults at Increased Risk for Diabetes (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/diabetesfinalrsbulletin.pdf
     October 27, 2015 - U.S. Preventive Task Force Recommends Screening Adults at Increased Risk for Diabetes USPSTF Bulletin An independent, volunteer panel of national experts in prevention and evidence-based medicine U.S. Preventive Task Force Recommends Screening Adults at Increased Risk for Diabetes Task Force recommends scr…

126. Archived: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/asymptomatic-bacteriuria-in-adults-screening-2008
     July 15, 2008 - It also states that screening for asymptomatic bacteriuria in nonpregnant women, diabetic women, or community-dwelling

127. Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Gestational Diabetes Mellitus | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-and-draft-evidence-review-screening-gestational-diabetes-mellitus
     March 15, 2021 - Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Gestational Diabetes Mellitus Share to Facebook Share to X Share to WhatsApp Share to Email Print February 16, 2021 – The U.S. Preventive Services Task …

128. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/whbbEX529Ha4FyvsYv6uh6
     April 26, 2022 - Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients … Pharmacotherapy of Diabetes: New Developments: Improving Life and Prognosis for Diabetic Patients. … Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure … Effect of low-dose aspirin on primary prevention of cardiovascular events in Japanese diabetic patients … Aspirin possibly reduces cerebrovascular events in type 2 diabetic patients with higher C-reactive protein

129. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/2GDCmTe7akyrAHsTMbfz72
     May 06, 2022 - Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients … Pharmacotherapy of Diabetes: New Developments: Improving Life and Prognosis for Diabetic Patients. … Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure … Effect of low-dose aspirin on primary prevention of cardiovascular events in Japanese diabetic patients … Aspirin possibly reduces cerebrovascular events in type 2 diabetic patients with higher C-reactive protein

130. Twelfth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/reports-congress/twelfth-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services
     January 01, 2022 - Twelfth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services Share to Facebook Share to X Share to WhatsApp Share to Email Print The U.S. Preventive Services Task Force (USPSTF) has released its “12th Annu…

131. Recommendation: Gestational Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/gestational-diabetes-mellitus-screening1
     February 09, 2021 - Gestational Diabetes: Screening An Update for This Topic is In Progress LAST UPDATED: Feb 09, 2021 The Task Force keeps recommendations as current as possible by routinely updating existing recommendations and developing new recommendations. A multistep process is followed for each recommendation. The Task Forc…

132. Recommendation: Gestational Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/gestational-diabetes-screening
     August 03, 2021 - Gestational Diabetes: Screening An Update for This Topic is In Progress LAST UPDATED: Aug 03, 2021 The Task Force keeps recommendations as current as possible by routinely updating existing recommendations and developing new recommendations. A multistep process is followed for each recommendation. The Task Forc…

133. Recommendation: Screening for Prediabetes and Type 2 Diabetes | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/prediabetes-and-type-2-diabetes-screening
     March 10, 2021 - Screening for Prediabetes and Type 2 Diabetes An Update for This Topic is In Progress LAST UPDATED: Mar 10, 2021 The Task Force keeps recommendations as current as possible by routinely updating existing recommendations and developing new recommendations. A multistep process is followed for each recommendation.…

134. W-9Tarc9Nkw6Pe4Sfddmkz (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/W-9TArc9nkw6Pe4sfddMKZ
     July 01, 2013 - Benefits and Harms of Treating Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research Lisa Hartling, PhD; Donna M. Dryden, PhD; Alyssa Guthrie, MSSc; Melanie Muise, MA; Ben Vanderme…

135. EHC Releases Gestational Diabetes Evidence Report for Public Comment | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/ehc-releases-gestational-diabetes-evidence-report-public-comment
     June 09, 2012 - EHC Releases Gestational Diabetes Evidence Report for Public Comment Share to Facebook Share to X Share to WhatsApp Share to Email Print June 9, 2012 – AHRQ's Effective Healthcare Program This link goes offsite. Click to read the external li…

136. Final Recommendation Statement: Screening for Gestational Diabetes Mellitus | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-screening-gestational-diabetes-mellitus
     January 14, 2014 - Final Recommendation Statement: Screening for Gestational Diabetes Mellitus Share to Facebook Share to X Share to WhatsApp Share to Email Print January 14, 2014 – The U.S. Preventive Services Task Force released today a final Recommendation S…

137. Final Recommendation Statement: Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-screening-abnormal-blood-glucose-and-type-2-diabetes-mellitus
     October 27, 2015 - Final Recommendation Statement: Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus Share to Facebook Share to X Share to WhatsApp Share to Email Print October 27, 2015 – The U.S. Preventive Services Task Force released today a …

138. U.S. Preventive Services Task Force Issues Final Research Plan for Final Research Plan: Screening for Type 2 Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-issues-final-research-plan-final-research-plan-screening-type-2-diabetes-mellitus-impaired-fasting
     August 15, 2013 - U.S. Preventive Services Task Force Issues Final Research Plan for Final Research Plan: Screening for Type 2 Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance Share to Facebook Share to X Share to WhatsApp Share to Email Print …

139. 12th Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2022-annual-report-to-congress.pdf
     January 01, 2022 - 12th Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services November 2021 High-Priority Evidence Gaps for Clinical Preventive Services SUBMITTED BY: Dr. Carol M. Mangione, Chair Dr. Michael J. Barry, Vice Chair Dr. Wanda K. Nicholson, Vice Chair ON BEHALF OF THE U.S. PREVENTIVE…

140. Final Recommendation Statement: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/statin-use-in-adults-preventive-medication
     August 23, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication August 23, 2022 Recommendations made by the USP…